Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337624

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337624

Specialty Enzymes Market Size and Share Analysis by Type, Source, Application - Global Industry Demand Forecast to 2030

PUBLISHED:
PAGES: 310 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The specialty enzymes market will touch USD 8,921.8 million, propelling at a 7.6% compound annual growth rate, by 2030. This growth can be credited to the rising utilization of such enzymes for the growth of medications, the growing requirement for non-risky organic catalysts in the diagnostics and pharma industries, and the increasing occurrence of chronic health illnesses throughout the world.

Enzymes play an important role in numerous applications in the healthcare sector from the detection of illnesses to medication manufacturing. Here, biocatalysts are developing technology for the discovery of small molecule active pharmaceutical ingredients and are utilized on a vast scale to make specialty compounds. Therefore, the growth and availability of a huge count of enzymes to biological pharmacists have made bio-catalysis a more profitable and reasonable manufacturing choice.

On the basis of application, the research & biotechnology category is estimated to advance at a substantial CAGR during the projection period. This can be because of the growth in analytic tests, the lessening in DNA sequencing prices, a surge in testing of agricultural, food & beverages, and therapeutic items, and massive medicinal players that continue fuelling research and development investments in biologics for the development of novel drug pipelines.

In 2022, on the basis of source, the microorganisms category had the highest industry value, approximately USD 3 billion, and the category is also projected to remain dominant in the future as well. This is mainly because enzymes brought out from bacterial sources result in lesser making prices and can be cultured in huge amounts within a short span of time, and also comprise greater foreseeable and manageable enzyme content.

On the basis of type, the polymerases & nucleases category is leading the industry. This is because such enzymes catalyze the synthesis of RNA and DNA, as they are crucial for all nucleic acid processing, which comprises transcription, repetition, recombination, and restoration; and these are progressively utilized in the fields of biocatalysts, pharmaceuticals, diagnostics, and biotechnology R&D. Furthermore, the increased utilization of these enzymes in progressive biotech applications like DNA sequencing and amplification is projected to fuel the industry development in this category during the projection period.

In 2022, the North American specialty enzymes market held the largest revenue share, of around 45%, and it is projected to advance at a compound annual growth rate of 7% during the projection period. This is credited to the technical developments that made enzymes obtainable across a wide variety of applications, the growth of pioneering and high-performance items, high financial development, the existence of major market players, and the rising pharmaceutical sector, in the continent.

Product Code: 12662

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by source
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

  • 6.1. Market Dynamics
    • 6.1.1. Trends
    • 6.1.2. Drivers
    • 6.1.3. Restraints/challenges
    • 6.1.4. Impact analysis of drivers/restraints
  • 6.2. Impact of COVID-19
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Bargaining power of buyers
    • 6.3.2. Bargaining power of suppliers
    • 6.3.3. Threat of new entrants
    • 6.3.4. Intensity of rivalry
    • 6.3.5. Threat of substitutes

Chapter 7. Global Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Source (2017-2030)
  • 7.5. Market Revenue, by Source (2017-2030)
  • 7.6. Market Volume, by Application (2017-2030)
  • 7.7. Market Revenue, by Application (2017-2030)
  • 7.8. Market Volume, by Region (2017-2030)
  • 7.9. Market Revenue, by Region (2017-2030)

Chapter 8. North America Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Source (2017-2030)
  • 8.5. Market Revenue, by Source (2017-2030)
  • 8.6. Market Volume, by Application (2017-2030)
  • 8.7. Market Revenue, by Application (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. Europe Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Source (2017-2030)
  • 9.5. Market Revenue, by Source (2017-2030)
  • 9.6. Market Volume, by Application (2017-2030)
  • 9.7. Market Revenue, by Application (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. APAC Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Source (2017-2030)
  • 10.5. Market Revenue, by Source (2017-2030)
  • 10.6. Market Volume, by Application (2017-2030)
  • 10.7. Market Revenue, by Application (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. LATAM Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Source (2017-2030)
  • 11.5. Market Revenue, by Source (2017-2030)
  • 11.6. Market Volume, by Application (2017-2030)
  • 11.7. Market Revenue, by Application (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. MEA Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Source (2017-2030)
  • 12.5. Market Revenue, by Source (2017-2030)
  • 12.6. Market Volume, by Application (2017-2030)
  • 12.7. Market Revenue, by Application (2017-2030)
  • 12.8. Market Volume, by Country (2017-2030)
  • 12.9. Market Revenue, by Country (2017-2030)

Chapter 13. U.S. Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Source (2017-2030)
  • 13.5. Market Revenue, by Source (2017-2030)
  • 13.6. Market Volume, by Application (2017-2030)
  • 13.7. Market Revenue, by Application (2017-2030)

Chapter 14. Canada Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Source (2017-2030)
  • 14.5. Market Revenue, by Source (2017-2030)
  • 14.6. Market Volume, by Application (2017-2030)
  • 14.7. Market Revenue, by Application (2017-2030)

Chapter 15. Germany Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Source (2017-2030)
  • 15.5. Market Revenue, by Source (2017-2030)
  • 15.6. Market Volume, by Application (2017-2030)
  • 15.7. Market Revenue, by Application (2017-2030)

Chapter 16. France Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Source (2017-2030)
  • 16.5. Market Revenue, by Source (2017-2030)
  • 16.6. Market Volume, by Application (2017-2030)
  • 16.7. Market Revenue, by Application (2017-2030)

Chapter 17. U.K. Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Source (2017-2030)
  • 17.5. Market Revenue, by Source (2017-2030)
  • 17.6. Market Volume, by Application (2017-2030)
  • 17.7. Market Revenue, by Application (2017-2030)

Chapter 18. Italy Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Source (2017-2030)
  • 18.5. Market Revenue, by Source (2017-2030)
  • 18.6. Market Volume, by Application (2017-2030)
  • 18.7. Market Revenue, by Application (2017-2030)

Chapter 19. Spain Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Source (2017-2030)
  • 19.5. Market Revenue, by Source (2017-2030)
  • 19.6. Market Volume, by Application (2017-2030)
  • 19.7. Market Revenue, by Application (2017-2030)

Chapter 20. Japan Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Source (2017-2030)
  • 20.5. Market Revenue, by Source (2017-2030)
  • 20.6. Market Volume, by Application (2017-2030)
  • 20.7. Market Revenue, by Application (2017-2030)

Chapter 21. China Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Source (2017-2030)
  • 21.5. Market Revenue, by Source (2017-2030)
  • 21.6. Market Volume, by Application (2017-2030)
  • 21.7. Market Revenue, by Application (2017-2030)

Chapter 22. India Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Source (2017-2030)
  • 22.5. Market Revenue, by Source (2017-2030)
  • 22.6. Market Volume, by Application (2017-2030)
  • 22.7. Market Revenue, by Application (2017-2030)

Chapter 23. Australia Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Source (2017-2030)
  • 23.5. Market Revenue, by Source (2017-2030)
  • 23.6. Market Volume, by Application (2017-2030)
  • 23.7. Market Revenue, by Application (2017-2030)

Chapter 24. South Korea Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Source (2017-2030)
  • 24.5. Market Revenue, by Source (2017-2030)
  • 24.6. Market Volume, by Application (2017-2030)
  • 24.7. Market Revenue, by Application (2017-2030)

Chapter 25. Brazil Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Source (2017-2030)
  • 25.5. Market Revenue, by Source (2017-2030)
  • 25.6. Market Volume, by Application (2017-2030)
  • 25.7. Market Revenue, by Application (2017-2030)

Chapter 26. Mexico Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Source (2017-2030)
  • 26.5. Market Revenue, by Source (2017-2030)
  • 26.6. Market Volume, by Application (2017-2030)
  • 26.7. Market Revenue, by Application (2017-2030)

Chapter 27. Saudi Arabia Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Source (2017-2030)
  • 27.5. Market Revenue, by Source (2017-2030)
  • 27.6. Market Volume, by Application (2017-2030)
  • 27.7. Market Revenue, by Application (2017-2030)

Chapter 28. South Africa Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Source (2017-2030)
  • 28.5. Market Revenue, by Source (2017-2030)
  • 28.6. Market Volume, by Application (2017-2030)
  • 28.7. Market Revenue, by Application (2017-2030)

Chapter 29. U.A.E. Market

  • 29.1. Overview
  • 29.2. Market Volume, by Type (2017-2030)
  • 29.3. Market Revenue, by Type (2017-2030)
  • 29.4. Market Volume, by Source (2017-2030)
  • 29.5. Market Revenue, by Source (2017-2030)
  • 29.6. Market Volume, by Application (2017-2030)
  • 29.7. Market Revenue, by Application (2017-2030)

Chapter 30. Competitive Landscape

  • 30.1. List of Market Players and their Offerings
  • 30.2. Competitive Benchmarking of Key Players
  • 30.3. Product Benchmarking of Key Players
  • 30.4. Recent Strategic Developments

Chapter 31. Company Profiles

  • 31.1. BASF SE
    • 31.1.1. Business overview
    • 31.1.2. Product and service offerings
    • 31.1.3. Key financial summary
  • 31.2. BBI Solutions
    • 31.2.1. Business overview
    • 31.2.2. Product and service offerings
  • 31.3. BRAIN Biotech AG
    • 31.3.1. Business overview
    • 31.3.2. Product and service offerings
    • 31.3.3. Key financial summary
  • 31.4. Codexis Inc.
    • 31.4.1. Business overview
    • 31.4.2. Product and service offerings
    • 31.4.3. Key financial summary
  • 31.5. Amano Enzyme Europe Limited
    • 31.5.1. Business overview
    • 31.5.2. Product and service offerings
  • 31.6. DuPont de Nemours Inc.
    • 31.6.1. Business overview
    • 31.6.2. Product and service offerings
    • 31.6.3. Key financial summary
  • 31.7. F. Hoffmann-La Roche Ltd.
    • 31.7.1. Business overview
    • 31.7.2. Product and service offerings
    • 31.7.3. Key financial summary
  • 31.8. Koninklijke DSM N.V.
    • 31.8.1. Business overview
    • 31.8.2. Product and service offerings
    • 31.8.3. Key financial summary
  • 31.9. Novozymes A/S
    • 31.9.1. Business overview
    • 31.9.2. Product and service offerings
    • 31.9.3. Key financial summary
  • 31.10. Specialty Enzymes & Probiotics
    • 31.10.1. Business overview
    • 31.10.2. Product and service offerings
  • 31.11. Merck KGaA
    • 31.11.1. Business overview
    • 31.11.2. Product and service offerings
    • 31.11.3. Key financial summary
  • 31.12. Aumgene Biosciences
    • 31.12.1. Business overview
    • 31.12.2. Product and service offerings
  • 31.13. Dyadic International Inc.
    • 31.13.1. Business overview
    • 31.13.2. Product and service offerings
    • 31.13.3. Key financial summary
  • 31.14. Advanced Enzyme Technologies Limited
    • 31.14.1. Business overview
    • 31.14.2. Product and service offerings
    • 31.14.3. Key financial summary
  • 31.15. AB Enzymes GmbH
    • 31.15.1. Business overview
    • 31.15.2. Product and service offerings

Chapter 32. Appendix

  • 32.1. Abbreviations
  • 32.2. Sources and References
  • 32.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!